Identifier
Created
Classification
Origin
08SEOUL107
2008-01-18 03:18:00
UNCLASSIFIED
Embassy Seoul
Cable title:
COMBAT METH EPIDEMIC ACT: ROKG PARTICIPATES IN
how-toVZCZCXYZ0004 PP RUEHWEB DE RUEHUL #0107 0180318 ZNR UUUUU ZZH P 180318Z JAN 08 FM AMEMBASSY SEOUL TO SECSTATE WASHDC PRIORITY 8106
UNCLAS SEOUL 000107
SIPDIS
SIPDIS
INL FOR JOHN LYLE
E.O. 12958: N/A
TAGS: SNAR ETRD ECON KS
SUBJECT: COMBAT METH EPIDEMIC ACT: ROKG PARTICIPATES IN
INCB PRE-NOTIFICATION SYSTEM
REF: SECSTATE 686
UNCLAS SEOUL 000107
SIPDIS
SIPDIS
INL FOR JOHN LYLE
E.O. 12958: N/A
TAGS: SNAR ETRD ECON KS
SUBJECT: COMBAT METH EPIDEMIC ACT: ROKG PARTICIPATES IN
INCB PRE-NOTIFICATION SYSTEM
REF: SECSTATE 686
1. (U) Per reftel request, POLOFF confirmed that the Republic
of Korea Government (ROKG) reported their 2006 legitimate
domestic requirements for the licit use of ephedrine and
psuedoephedrine to the International Narcotics Control Board
(INCB) through the ROK Ministry of Foreign Affairs and Trade.
The 2006 annual estimates for licit requirements are 15,950
Kg of ephedrine and 32,500 Kg of psuedoephedrine. Hong
Soon-wook, Director of the Narcotics Control Team of the
Korean Food and Drug Administration (KFDA),advised POLOFF
that as a "Group 1 Raw Substance," the KFDA must approve all
exports of psuedoephedrine. As part of the export approval
process, Hong verified that the KFDA transmits a pre-export
notification to the INCB and to the importer.
STANTON
SIPDIS
SIPDIS
INL FOR JOHN LYLE
E.O. 12958: N/A
TAGS: SNAR ETRD ECON KS
SUBJECT: COMBAT METH EPIDEMIC ACT: ROKG PARTICIPATES IN
INCB PRE-NOTIFICATION SYSTEM
REF: SECSTATE 686
1. (U) Per reftel request, POLOFF confirmed that the Republic
of Korea Government (ROKG) reported their 2006 legitimate
domestic requirements for the licit use of ephedrine and
psuedoephedrine to the International Narcotics Control Board
(INCB) through the ROK Ministry of Foreign Affairs and Trade.
The 2006 annual estimates for licit requirements are 15,950
Kg of ephedrine and 32,500 Kg of psuedoephedrine. Hong
Soon-wook, Director of the Narcotics Control Team of the
Korean Food and Drug Administration (KFDA),advised POLOFF
that as a "Group 1 Raw Substance," the KFDA must approve all
exports of psuedoephedrine. As part of the export approval
process, Hong verified that the KFDA transmits a pre-export
notification to the INCB and to the importer.
STANTON